SeaCrest Wealth Management LLC Raises Position in Zoetis Inc. (NYSE:ZTS)

SeaCrest Wealth Management LLC grew its position in shares of Zoetis Inc. (NYSE:ZTS) by 2.8% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,968 shares of the company’s stock after buying an additional 108 shares during the quarter. SeaCrest Wealth Management LLC’s holdings in Zoetis were worth $775,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in ZTS. Nomura Holdings Inc. bought a new position in shares of Zoetis during the fourth quarter valued at $1,825,000. NBC Securities Inc. boosted its holdings in shares of Zoetis by 12.7% during the 1st quarter. NBC Securities Inc. now owns 7,414 shares of the company’s stock valued at $1,254,000 after acquiring an additional 838 shares during the last quarter. Czech National Bank grew its stake in shares of Zoetis by 0.4% in the first quarter. Czech National Bank now owns 80,781 shares of the company’s stock worth $13,669,000 after acquiring an additional 357 shares during the period. BTC Capital Management Inc. purchased a new position in shares of Zoetis during the first quarter valued at approximately $6,896,000. Finally, PFW Advisors LLC bought a new position in Zoetis during the first quarter valued at approximately $1,845,000. Institutional investors own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on ZTS. BTIG Research boosted their target price on shares of Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, August 12th. JPMorgan Chase & Co. upped their price objective on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Stifel Nicolaus boosted their price target on Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research note on Wednesday, September 18th. Piper Sandler increased their price objective on shares of Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 14th. Finally, Argus upgraded shares of Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. Ten equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Buy” and an average target price of $221.44.

Zoetis Stock Up 1.1 %

ZTS opened at $194.45 on Thursday. The stock has a market cap of $88.10 billion, a price-to-earnings ratio of 38.05, a price-to-earnings-growth ratio of 2.99 and a beta of 0.89. The company has a debt-to-equity ratio of 1.32, a quick ratio of 2.09 and a current ratio of 3.45. The firm’s fifty day moving average is $188.76 and its 200 day moving average is $176.70. Zoetis Inc. has a fifty-two week low of $144.80 and a fifty-two week high of $201.92.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Tuesday, August 6th. The company reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.49 by $0.07. The firm had revenue of $2.36 billion during the quarter, compared to analyst estimates of $2.31 billion. Zoetis had a return on equity of 50.67% and a net margin of 26.29%. The business’s quarterly revenue was up 8.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.41 earnings per share. On average, sell-side analysts forecast that Zoetis Inc. will post 5.83 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Stockholders of record on Thursday, October 31st will be issued a $0.432 dividend. This represents a $1.73 annualized dividend and a dividend yield of 0.89%. The ex-dividend date is Thursday, October 31st. Zoetis’s dividend payout ratio (DPR) is presently 33.86%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.